GSK3B and diabetes mellitus: Emerging evidence indicates that both IPC- and Ipost-mediated myocardial protection predominantly be mediated by stimulating PI3K/Akt and associated GSK-3β pathway while diabetes-mediated pathogenic effects are found to be mediated by inhibiting PI3K/Akt and associated GSK-3β pathway.